• Listed Companies
  • Announcements
  • ASMPT LIMITED
  • EN
  • 繁
  • 简
  • 2025 Mar 31
    16:42

    Proxy Forms

    FORM OF PROXY FOR 2025 ANNUAL GENERAL MEETING

    00522 - ASMPT LIMITED


  • 2025 Mar 31
    16:40

    Notice of AGM / Closure of Books or Change of Book Closure Period

    NOTICE OF 2025 ANNUAL GENERAL MEETING

    00522 - ASMPT LIMITED


  • 2025 Mar 27
    16:34

    Change in Directors or of Important Executive Functions or Responsibilities / Change of Audit Committee Member / Change of Remuneration Committee Member

    CHANGES IN DIRECTORSHIPS

    00522 - ASMPT LIMITED


  • 2025 Mar 27
    06:34

    Share Scheme

    AWARD OF SHARES PURSUANT TO THE COMPANY'S EMPLOYEE SHARE INCENTIVE SCHEME

    00522 - ASMPT LIMITED


  • 2025 Mar 03
    06:33

    Discloseable Transaction

    DISCLOSEABLE TRANSACTION - DISPOSAL OF ASSETS

    00522 - ASMPT LIMITED


  • 2025 Feb 26
    07:11

    Other - Trading Update

    PRESS RELEASE OF 2024 ANNUAL RESULTS

    00522 - ASMPT LIMITED


  • 2025 Feb 26
    07:09

    Dividend or Distribution (Announcement Form)

    SPECIAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024

    00522 - ASMPT LIMITED


  • 2025 Feb 26
    07:07

    Dividend or Distribution (Announcement Form)

    FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024

    00522 - ASMPT LIMITED


  • 2025 Feb 26
    07:05

    Final Results / Dividend or Distribution / Closure of Books or Change of Book Closure Period

    ANNOUNCEMENT OF 2024 AUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024

    00522 - ASMPT LIMITED


  • 2025 Feb 19
    16:50

    Change in Share Registrar/Transfer Agent

    CHANGE OF SHARE REGISTRAR AND TRANSFER OFFICE IN HONG KONG

    00522 - ASMPT LIMITED


  • «
  • ‹
  • 1
  • 2
  • 3
  • 4
  • ›
  • »

Address

1/F, China Building,
29 Queen's Road Central, Hong Kong
(852) 3693 2688
info@cre8corp.com

Sitemap

  • Listed Companies
  • Disclaimer
  • Privacy Policy

Newsletter

Fill your email and sign up for monthly newsletter to keep updated

© Cre8ir 2023 All right reserved.